For the Inventor, By the Inventor

Enter assignee name

Austin, TX, United States of America

Vermillion Corporation

Calculating rank

USPTO Granted Patents = 26

% Expired Patents = 26.9

EPO Patents = 3

Trademarks = 13

Forward Citations = 210

Loading Chart...

Loading Chart...

47 inventors (with patents filed for the assignee):

Eric Thomas Fung (14 out of 20 patents)

John P Cooke (6 out of 43 patents)

Tai-Tung Yip (5 out of 35 patents)

4. Vladimir Podust (4 out of 10 patents)

5. Zhen Zhang (4 out of 17 patents)

6. Ping F Yip (4 out of 4 patents)

7. Suraj Amonkar (4 out of 4 patents)

8. Greg P Bertenshaw (4 out of 4 patents)

9. Daniel W Chan (4 out of 11 patents)

10. Brian C Mansfield (4 out of 5 patents)

11. Xiao-Ying Meng (4 out of 4 patents)

12. Walter Wilcox Cardwell, Iii (4 out of 5 patents)

13. Stephen Andrew Stickel (4 out of 4 patents)

14. Fujun Zhang (3 out of 4 patents)

15. Eiichiro Kimura (3 out of 19 patents)

Core Competencies:

Ovarian Cancer

Biomarkers

Peripheral Artery Disease

CTAP3

Beta-2 Microglobulin

Cancer Diagnostics

Panel of Biomarkers

Lung Cancer

Alzheimer's Disease

Natriuretic Peptides

Nephrotic Syndrome

Diagnostic Methods

26 patents: Sort by Forward Citations

1. 10605811 - Predictive biomarkers for ovarian cancer (2020-03-31),

2. 9846158 - Predictive biomarkers for ovarian cancer (2017-12-19),

3. 9816995 - Biomarker for ovarian cancer CTAP3-related proteins (2017-11-14),

4. 9274118 - Predictive markers for ovarian cancer (2016-03-01),

5. 8709735 - β-2 microglobulin as a biomarker for peripheral artery disease (2014-04-29),

6. 8682591 - Biomarkers for ovarian cancer (2014-03-25),

7. 8664358 - Predictive markers for ovarian cancer (2014-03-04),

8. 8465929 - Biomarkers for ovarian cancer (2013-06-18),

9. 8377646 - Beta-2 microglobulin as a biomarker for peripheral artery disease (2013-02-19),

10. 8221984 - Biomarkers for ovarian cancer (2012-07-17),

11. 8206934 - Methods for diagnosing ovarian cancer (2012-06-26),

12. 8173433 - Platelet biomarkers for cancer (2012-05-08),

13. 8053204 - Beta-2 microglobulin as a biomarker for peripheral artery disease (2011-11-08),

14. 8014952 - Serum biomarkers in lung cancer (2011-09-06),

15. 8008020 - Biomarkers for peripheral artery disease (2011-08-30),

Company Overview

Vermillion Corporation is a biotechnology company based in Austin, Texas, specializing in the development of innovative diagnostics and therapeutic solutions. The organization focuses on women's health, particularly in the areas of ovarian cancer and other gynecological conditions, leveraging advanced biomarker technologies to enhance patient outcomes. Through its commitment to research and development, Vermillion aims to provide healthcare professionals with critical tools for early detection and personalized treatment strategies.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

26 Patents

#116 in Austin, TX

#739 in Texas

#12,875 in US

#24,848 in the World

Austin, TX, United States of America

Vermillion Corporation

Forward Citations = 210

47 inventors:

Eric Thomas Fung (14 out of 20 patents)

John P Cooke (6 out of 43 patents)

Tai-Tung Yip (5 out of 35 patents)

4. Vladimir Podust (4 out of 10 patents)

5. Zhen Zhang (4 out of 17 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Vermillion Corporation. Retrieved from https://idiyas.com/company/vermillion

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…